Search results
Drug compounds to combat neurodegenerative diseases
Science Daily· 2 days agoThe central event in these diseases is the conversion of the prion protein (PrPC) from its normal shape into a pathological structure (PrPSc) that is toxic to neurons and can replicate itself ...
NKGen Biotech Announces Upcoming Presentation on Autologous NK Cell Therapy at the 5th International...
Benzinga· 9 hours ago...Officer of NKGen, will present highlights of the Company's cryopreserved, autologous, non-genetically modified NK cell therapy product, SNK01, which has demonstrated enhanced cytotoxicity and activating receptor expression for the treatment of neurodegenerative diseases and solid tumors, at the...
Study shows vicious cycle of protein clumping in Alzheimer's disease and normal aging
Medical Xpress· 1 hour agoBuck researchers have recently completed a systematic study in worms that paints an intricate picture of the connections between insoluble proteins in neurodegenerative < ...
Scientists Unravel Genetic Basis for Neurodegenerative Disorders that Affect Vision, NIH Reports
Sierra Sun Times· 8 hours agoLed by researchers at the National Institutes of Health (NIH), a team of scientists has uncovered the complex molecular mechanisms underlying neurodegenerative disorders linked ...
Roche (RHHBY) Posts Encouraging Phase I Obesity Drug Data
Zacks via Yahoo Finance· 8 hours agoData from the study shows that nearly half of the patients who received Roche's (RHHBY)...
Biogen, Ionis to discontinue development of experimental ALS drug
Reuters via AOL· 10 hours agoShares of Biogen and Ionis were each down nearly 2% in premarket trading. This marks another setback...
Biogen and Ionis Pharma shares slide as they end development of ALS treatment
Market Watch· 3 hours agoIt also did not show an impact on clinical outcome measures relating to function, breathing and...
Governor signs off on Progressive Supranuclear Palsy committee
Florida Politics· 5 days agoDeSantis. SB 186, colloquially called the “Justo R. Cortes Progressive Supranuclear Palsy Act,”...
Clene (NASDAQ: CLNN) Announces Participation Schedule for May Conferences
Digital Journal· 1 day agoClene will participate in one-on-one meetings at the Mizuho Neuroscience Summit 2024, the Benchmark 2024 Healthcare House...
Promising new study could lead to a reduction in symptoms of amyotrophic lateral sclerosis
Medical Xpress· 2 days agoThere are few effective treatments available to slow the progression of ALS and, unfortunately, most...
